Clinical trials
Biopsy clinical trials
Below are recruiting biopsy clinical trials, each written for real people, not researchers. We’re tracking 967 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07491328Recruiting
Liquid biopsy for nerve disorders linked to cancer
This study uses a blood test (liquid biopsy) to look for cancer-related signals in people with certain nerve disorders caused by the immune system (paraneoplastic neurological syndromes) or in people with tumors that do not affect the nerves. It aims to better understand and detect these conditions.
DüsseldorfAges 18 years+ - NCT07500818Recruiting
Robot vs. standard scope for lung biopsy in ILD
This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.
Lucerne, Canton of LucerneAges Any age - NCT07510334RecruitingPhase 2
VSV Virus Plus Immunotherapy for Advanced Kidney Cancer
This trial tests a combination of a special virus (VSV-IFNβ-NIS) with two immunotherapy drugs (ipilimumab and nivolumab) for people with advanced clear cell kidney cancer that hasn't been treated yet. It aims to see if this approach helps shrink tumors or slow the disease.
Rochester, MinnesotaAges 18 years+ - NCT07516223Recruiting
MRI-guided prostate biopsy to reduce unnecessary tissue sampling
This study tests whether using MRI imaging to guide prostate biopsies can help doctors sample only suspicious areas instead of taking many samples throughout the prostate. It may reduce discomfort and complications while still finding prostate cancer if present.
ShanghaiAges 45 years+ - NCT07531329Recruiting
Delayed PSMA imaging to detect aggressive prostate cancer
This study tests whether a special type of imaging scan (PSMA PET/CT with delayed imaging) can better identify aggressive prostate cancer in men who haven't had a biopsy yet. The goal is to help doctors decide who really needs a biopsy and avoid unnecessary procedures.
Lanzhou, GansuAges 18 years+ - NCT07538947Recruiting
Real-time imaging to diagnose lung cancer faster and safer
This trial tests a new camera tool (confocal laser endomicroscopy) that lets doctors see lung tissue in real-time during a biopsy procedure. The goal is to diagnose non-small cell lung cancer more quickly and safely than standard biopsies alone.
NancyAges 18 years+ - NCT07553754Recruiting
Blood test to predict prostate cancer spread to bones
This study examines special particles in your blood called exosomes to see if they can predict whether prostate cancer might spread to your bones. Researchers will collect a blood sample before any cancer treatment to look for RNA signatures that might indicate bone metastasis risk.
Lanzhou, GansuAges 18 years+ - NCT07560865RecruitingPhase 1
New Cell Therapy for Recurring Brain Cancer
This study tests FT536, a new cell-based treatment, for people with a specific type of brain cancer (WHO Grade 4 astrocytoma) that has come back after standard treatment. The trial combines the new therapy with surgery to see if it can help stop the cancer from growing further.
Minneapolis, MinnesotaAges 18–75 - NCT07563036Recruiting
JAK2 Protein Changes in Male Pattern Baldness With Minoxidil
This study examines how a protein called JAK2 changes in the scalp when men with male pattern baldness use minoxidil (Rogaine), a common hair-loss treatment. Understanding this might help explain why minoxidil works and improve future treatments.
Cairo, Cairo GovernorateAges 18–50 - NCT07568613Recruiting
PSMA PET/CT versus MRI for mapping prostate cancer
This trial compares two imaging techniques—PSMA PET/CT and MRI—to see which one better finds and outlines prostate cancer tumors. You'll receive both scans to help doctors understand which method works best for newly diagnosed prostate cancer.
LimassolAges 18 years+ - NCT07584291Recruiting
Blood Tests and Tissue Study for Melanoma
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
Xi'an, ShaanxiAges 18–80 - NCT07654166Recruiting
Glue vs stitches for mouth growth removal
This trial compares using a skin glue (tissue adhesive) versus stitches (sutures) to close the small wound after removing a harmless growth inside your mouth. It may help reduce discomfort and healing time.
Damascus, MazzhAges 18–80 - NCT07417774Enrolling by invitation
Blood test monitoring for glioblastoma treated with chemoradiation and oxygen therapy
This substudy looks at a blood test (liquid biopsy) to track glioblastoma during standard chemoradiation and an experimental oxygen-boosting drug. It aims to see if the test can help monitor the tumor more easily than scans alone.
Tucson, ArizonaAges 18 years+ - NCT07349966Enrolling by invitation
Biopsy effects on children born after genetic testing
This study compares children born after preimplantation genetic testing with a small biopsy of the embryo to those born without such testing. It aims to see if the biopsy affects a child's health and development during their first year of life.
Milan, MilanoAges Up to 5 years - NCT07217353Enrolling by invitation
Testing a new speculum for endometrial biopsies
This trial tests a new type of vaginal speculum designed to make endometrial biopsies (a procedure to take a small sample of the lining of the uterus) more comfortable and effective. If you have had this biopsy before at the Minnesota Oncology Clinic, you may be eligible to help evaluate this new tool.
Englewood, ColoradoAges 18–90 - NCT06997458Enrolling by invitation
Liquid biopsy study for advanced lung or colon cancer
This study is testing a simple blood draw (liquid biopsy) to track advanced lung or colon cancer. It may help doctors understand the cancer better without needing repeated tissue biopsies.
Granada, AndalusiaAges 18 years+ - NCT06801886Enrolling by invitationPhase 3
Silymarin for better kidney transplant success
This trial tests if adding silymarin (a milk thistle extract) to standard anti-rejection medicines helps protect the new kidney from damage. It may improve how well the transplanted kidney works over time.
MartinAges Any age - NCT06785922Enrolling by invitation
Stomach bacteria differences in H. pylori patients
This trial compares the types of bacteria in the stomach of people infected with different strains of H. pylori (CagA positive vs. negative). It may help researchers understand how these bacteria affect health.
Bangkok Noi, BangkokAges 18 years+ - NCT06768268Enrolling by invitationPhase 1/Phase 2
Better lymph node imaging for breast cancer
This trial tests whether adding two common fluids (Mannitol and Voluven) before an ICG dye injection can help surgeons better see the lymph nodes that need to be removed during breast cancer surgery. It aims to make sentinel lymph node biopsies more accurate and safer.
Hsinchu CountyAges 20–70 - NCT06606990RecruitingPhase 1
Testing the drug CX-5461 for advanced solid tumors
This trial tests a new drug called CX-5461 (also known as pidnarulex) in people whose cancer has spread and hasn't been helped by standard treatments. It looks at how your body responds to the drug, which may target cancers with specific DNA repair problems.
Bethesda, MarylandAges 18 years+ - NCT06505356Enrolling by invitation
Genetics and inflammation in prostate cancer stage
This study looks at the connection between genetics, inflammation, and prostate cancer stage. It aims to find markers that may help predict how aggressive the cancer is. You may be eligible if you are newly suspected of having prostate cancer and have not yet started treatment.
KaunasAges 18–100 - NCT06474091Enrolling by invitation
Blood monitoring for bile duct cancer treatment and outlook
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
Rochester, MinnesotaAges 18 years+ - NCT06223542RecruitingPhase 1
TAK-243 for advanced cancers that haven't responded to other treatments
This trial tests a new drug called TAK-243 for people with advanced cancers (solid tumors or lymphomas) that have not responded to other treatments. It aims to see if the drug is safe and how well it works.
Bethesda, MarylandAges 18 years+ - NCT06101940Enrolling by invitation
Chinese study tracking myotonic dystrophy type 1 outcomes
This study follows people with myotonic dystrophy type 1 (DM1) over time to learn more about how the disease progresses. It collects health information and samples to help improve care.
Beijing, Beijing MunicipalityAges Any age
Hear when a new Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biopsy?
- Yes. Clin2 currently lists 967 recruiting biopsy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biopsy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biopsy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.